Spire Healthcare Group (LON:SPI) had its price target decreased by JPMorgan Chase & Co. from GBX 339 ($4.68) to GBX 293 ($4.05) in a research report released on Monday. JPMorgan Chase & Co. currently has a neutral rating on the stock.

A number of other research analysts have also weighed in on SPI. Liberum Capital reaffirmed a hold rating and set a GBX 270 ($3.73) price objective on shares of Spire Healthcare Group in a research report on Thursday, November 16th. Berenberg Bank raised Spire Healthcare Group to a buy rating and raised their price objective for the company from GBX 270 ($3.73) to GBX 310 ($4.28) in a research report on Wednesday, November 29th. Numis Securities reiterated an add rating and set a GBX 296 ($4.09) target price on shares of Spire Healthcare Group in a research note on Tuesday, January 16th. Jefferies Group upgraded Spire Healthcare Group to a buy rating and increased their target price for the company from GBX 259 ($3.58) to GBX 290 ($4.01) in a research note on Wednesday, January 17th. Finally, Barclays began coverage on Spire Healthcare Group in a research note on Friday, February 2nd. They set an equal weight rating and a GBX 270 ($3.73) target price on the stock. One analyst has rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the stock. Spire Healthcare Group has a consensus rating of Hold and an average target price of GBX 295.57 ($4.08).

How to Become a New Pot Stock Millionaire

Spire Healthcare Group (LON:SPI) opened at GBX 217.40 ($3.00) on Monday. Spire Healthcare Group has a 52-week low of GBX 206.40 ($2.85) and a 52-week high of GBX 362.10 ($5.00). The firm has a market capitalization of $881.58 and a P/E ratio of 5,435.00.

Spire Healthcare Group (LON:SPI) last posted its quarterly earnings data on Friday, March 2nd. The company reported GBX 14.40 ($0.20) earnings per share for the quarter, missing the Zacks’ consensus estimate of GBX 14.60 ($0.20) by GBX (0.20) ($0.00). Spire Healthcare Group had a net margin of 1.85% and a return on equity of 1.71%. The company had revenue of £931.70 million for the quarter.

The firm also recently announced a dividend, which will be paid on Tuesday, June 26th. Shareholders of record on Thursday, May 31st will be paid a dividend of GBX 2.50 ($0.03) per share. This represents a yield of 1.12%. This is an increase from Spire Healthcare Group’s previous dividend of $1.30. The ex-dividend date of this dividend is Thursday, May 31st.

In other Spire Healthcare Group news, insider Justin Ash bought 46,500 shares of the business’s stock in a transaction on Tuesday, March 6th. The shares were acquired at an average cost of GBX 215 ($2.97) per share, for a total transaction of £99,975 ($138,125.17).

ILLEGAL ACTIVITY WARNING: This piece was originally posted by Daily Political and is the property of of Daily Political. If you are viewing this piece on another domain, it was illegally stolen and republished in violation of United States & international trademark and copyright legislation. The correct version of this piece can be accessed at https://www.dailypolitical.com/2018/03/14/spire-healthcare-group-spi-price-target-cut-to-gbx-293.html.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.

Analyst Recommendations for Spire Healthcare Group (LON:SPI)

Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.